2027 alertKaiser Permanente, Wellcare, Alignment Health Plan and 3 other companies end some Medicare Advantage plans in Nevada on December 31. (CMS data) 17 days left in Annual Enrollment (ends Dec. 7).Is your plan ending? →
Questions

Which drugs have Medicare negotiated prices in 2027?

On January 1, 2027, Medicare negotiated prices take effect for 15 more Part D drugs, including Ozempic, Rybelsus and Wegovy, Trelegy Ellipta, Xtandi and Ibrance. Six of the first 10, such as Eliquis and Jardiance, keep theirs. CMS says Stelara, Xarelto, Entresto and NovoLog/Fiasp leave the program. The prices apply in Nevada as in every state.

Drugs with Medicare negotiated prices in 2027

DrugCommonly used forNegotiated price since
Ozempic, Rybelsus, Wegovytype 2 diabetes; heart disease with diabetes or with obesity or overweight2027
Trelegy Ellipta, Breo Elliptaasthma, COPD2027
Otezla, Otezla XRplaque psoriasis, psoriatic arthritis, Behçet's mouth ulcers2027
Janumet, Janumet XR; Tradjentatype 2 diabetes2027
Xtandi, Ibrance, Calquence, Pomalystcancers (see cancer pills)2027
Ofevidiopathic pulmonary fibrosis2027
Linzess; Xifaxanchronic constipation and IBS; hepatic encephalopathy2027
Austedo, Austedo XR; Vraylarmovement disorders; bipolar disorder, depression, schizophrenia2027
Eliquisatrial fibrillation, blood clots2026
Jardiance, Farxigatype 2 diabetes, heart failure, kidney disease2026
Januviatype 2 diabetes2026
Enbrelrheumatoid arthritis, psoriasis2026
Imbruvicablood cancers2026

CMS posts each negotiated price on its "Selected drugs and negotiated prices" page. They aren't repeated here, because your plan, not the negotiated price, sets what you pay.

Drugs that lose their negotiated price on January 1, 2027

A drug leaves the program once a generic or biosimilar version is approved and marketed. CMS made that determination for four first-round drugs, effective January 1, 2027:

If you take one, read your plan's 2027 Annual Notice of Change.

Drugs selected for 2028

On January 27, 2026, CMS selected 15 drugs for prices starting January 1, 2028, including Trulicity, Biktarvy, Entyvio, Botox and the cancer pills Erleada, Kisqali, Verzenio and Lenvima. Some are paid under Part B, a first for the program.

What it means for you in Nevada

  1. Check the formulary, not the price list. A negotiated price doesn't mean any of Nevada's 9 standalone Part D plans for 2027, or your Medicare Advantage plan, covers the drug. Look up your drugs on PlanMatch or Medicare.gov's Plan Finder.
  2. Remember the yearly cap. Whatever the price, your 2027 out-of-pocket spending on covered Part D drugs stops at $2,400.
  3. Weight loss is still excluded. Semaglutide's negotiated price doesn't let Part D plans cover Wegovy for weight loss alone; CMS's separate Medicare GLP-1 Bridge covers it for eligible people through 2027.
  4. If your plan is ending, pick new drug coverage by December 31, 2026, to avoid a gap. See plans ending in 2027 and What if my Medicare Advantage plan is ending?
  5. Compare before December 7, 2026. You can request a call from a licensed insurance agent, who can compare plans from the companies they work with.

Nevada's Senior Rx program ended on December 31, 2023, so federal Extra Help is the main help with drug costs. All 25 drug pages: Medicare drug coverage in Nevada.

Sources

Part of the guide: Medicare drug coverage in Nevada: 25 drugs, plain English · All questions

Frequently asked questions

Does a negotiated price mean my copay goes down?

Not necessarily. The negotiated price (the law calls it a maximum fair price) is what Part D plans and pharmacies pay. Your copay or coinsurance is set by your plan, so check its 2027 formulary.

Does a negotiated price mean every Nevada plan covers the drug?

No. Each of Nevada's 9 standalone Part D plans for 2027, and each Medicare Advantage plan with drug coverage, decides its own formulary. Look up the drug on each plan you're comparing.

Which drugs are next?

On January 27, 2026, CMS selected 15 drugs for prices starting in 2028, including Trulicity, Biktarvy, Entyvio and Botox, and for the first time included drugs paid under Part B. It also chose Tradjenta for renegotiation.

Licensed insurance agents for Nevada

These independent insurance agents are licensed in Nevada and work with Benefits Life, the publisher of this site. When they enroll you in a plan, the agent and Benefits Life may be paid by the insurance company. Learn more.

David Gresl

David Gresl

Accepting new clients

Independent licensed insurance agent in Nevada

Las Vegas · English

Emily Montoya

Emily Montoya

5.0 out of 5 stars (15 reviews on MedicareAgents.com)

Accepting new clients

Independent licensed insurance agent in Nevada

Peyton, CO · English

Shoeb Ismail

Shoeb Ismail

5.0 out of 5 stars (1 review on MedicareAgents.com)

Accepting new clients

Independent licensed insurance agent in Nevada

Seattle, WA · English, Spanish

Liz OConner

Liz OConner

Accepting new clients

Independent licensed insurance agent in Nevada

Albuquerque, NM · English, Spanish

See all Nevada agents →

Request a call from

Only this agent gets your request. No cost to you.